Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOOKAD VTP vs Active Surveillance for Intermediate Risk Localized Prostate Cancer
NCT04225299Phase 3Withdrawn
- Sponsor
- Steba Biotech
- Start
- Mar 2020
- Primary completion
- Mar 2030
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of padeliporfin VTP, sponsored by Steba Biotech. Planned start Mar 2020; status: withdrawn.
02
Drugs
padeliporfin VTP
Beyond the preview
Go deeper on NCT04225299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04225299.